Understanding the clinical implications of the “non-classical” microbiome in chronic lung disease: a viewpoint

Steven L. Taylor, Aurélie Crabbé, Luke R. Hoffman, James D. Chalmers, Geraint B. Rogers

Research output: Contribution to journalEditorial

1 Citation (Scopus)

Abstract

In the late 1990s, molecular microbial system analytics started to be adapted and applied to chronic lung disease [1, 2]. These approaches revealed microbial diversity in respiratory samples that included many bacterial species more usually associated with the oropharynx (box 1 and figure 1). While contamination of samples by oropharyngeal microbes might account for a portion of these taxa, evidence also emerged that some of these species were proliferating within the lower airways under certain circumstances [3, 4].
Original languageEnglish
Article number2302281
Number of pages7
JournalEuropean Respiratory Journal
Volume63
Issue number2
DOIs
Publication statusPublished - Feb 2024

Keywords

  • microbiome
  • chronic lung disease
  • non-classical
  • molecular
  • microbial
  • respiratory

Fingerprint

Dive into the research topics of 'Understanding the clinical implications of the “non-classical” microbiome in chronic lung disease: a viewpoint'. Together they form a unique fingerprint.

Cite this